BIK/NBK gene as potential marker of prognostic and therapeutic target in breast cancer patients

被引:6
|
作者
Lopez-Munoz, Eunice [1 ]
Hernandez-Zarco, Adelina [1 ]
Garcia-Hernandez, Normand [1 ]
Alvarado-Cabrero, Isabel [2 ]
Zarco-Espinosa, Gelasio [3 ]
Salamanca-Gomez, Fabio
Arenas-Aranda, Diego [1 ]
机构
[1] Hosp Pediat Mexico City, Unidad Invest Med Genet Humana, Ctr Med Nacl Siglo XXI CMN S XXI, Inst Mexicano Seguro Social IMSS, Mexico City 06720, DF, Mexico
[2] Hosp Oncol, Serv Patol, CMN SXXI, IMSS, Mexico City 06720, DF, Mexico
[3] Hosp Oncol, Serv Tumores Mama, CMN S XXI, IMSS, Mexico City 06720, DF, Mexico
来源
CLINICAL & TRANSLATIONAL ONCOLOGY | 2012年 / 14卷 / 08期
关键词
BIK/NBK; Estrogen receptor; Breast cancer; ENDOPLASMIC-RETICULUM BIK; BCL-2 PROTEIN FAMILY; CELL-DEATH; ESTROGEN-RECEPTOR; INDUCED APOPTOSIS; MITOCHONDRIAL APOPTOSIS; PROTEASOME INHIBITORS; AROMATASE INHIBITORS; BH3-ONLY PROTEIN; DRUG-RESISTANCE;
D O I
10.1007/s12094-012-0845-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The purpose of this study is to determine the association between the BIK/NBK gene expression and estrogen receptor alpha expression. We determined the association of BIK/NBK gene expression by real time quantitative reverse transcription polymerase chain reaction and estrogen receptor alpha expression by immunohistochemistry in samples of breast cancer tissue. We found a statistically significant correlation of BIK/NBK gene expression with the estrogen receptor alpha expression (rho = 0.751, p = 0.004). For verify differences of BIK/NBK gene expression among ER alpha+ and ER alpha- breast cancer tissues, Mann-Whitney U test was performed, obtaining significant differences. BIK/NBK gene expression may have important clinical implications and provide predictive, prognostic or therapeutic marker in breast cancer patients according to the estrogen receptor alpha expression.
引用
收藏
页码:586 / 591
页数:6
相关论文
共 50 条
  • [1] BIK/NBK gene as potential marker of prognostic and therapeutic target in breast cancer patients
    Eunice López-Muñoz
    Adelina Hernández-Zarco
    Normand García-Hernández
    Isabel Alvarado-Cabrero
    Gelasio Zarco-Espinosa
    Fabio Salamanca-Gómez
    Diego Arenas-Aranda
    Clinical and Translational Oncology, 2012, 14 : 586 - 591
  • [2] Ghrelin is a prognostic marker and a potential therapeutic target in breast cancer
    Gronberg, Malin
    Ahlin, Cecilia
    Naeser, Ylva
    Janson, Eva Tiensuu
    Holmberg, Lars
    Fjallskog, Marie-Louise
    PLOS ONE, 2017, 12 (04):
  • [3] RUNX3 is a prognostic marker and potential therapeutic target in human breast cancer
    Bai, Jin
    Yong, Hong-Mei
    Chen, Fei-Fei
    Song, Wen-Bo
    Li, Chen
    Liu, Hui
    Zheng, Jun-Nian
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (11) : 1813 - 1823
  • [4] BRG1 Is a Prognostic Marker and Potential Therapeutic Target in Human Breast Cancer
    Bai, Jin
    Mei, Pengjin
    Zhang, Cuipeng
    Chen, Feifei
    Li, Chen
    Pan, Zhenqiang
    Liu, Hui
    Zheng, Junnian
    PLOS ONE, 2013, 8 (03):
  • [5] RUNX3 is a prognostic marker and potential therapeutic target in human breast cancer
    Jin Bai
    Hong-Mei Yong
    Fei-Fei Chen
    Wen-Bo Song
    Chen Li
    Hui Liu
    Jun-Nian Zheng
    Journal of Cancer Research and Clinical Oncology, 2013, 139 : 1813 - 1823
  • [6] Correlation of the protein expression of GRP78 and BIK/NBK with prognostic markers in patients with breast cancer and neoadjuvant chemotherapy
    Lopez-Munoz, Eunice
    Corres-Molina, Miguel
    Garcia-Hernandez, Normand
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2020, 40 (03) : 419 - 426
  • [7] The 9p21 locus: A potential therapeutic target and prognostic marker in breast cancer
    Rivandi, Mahdi
    Khorrami, Mohammad-Sadegh
    Fiuji, Hamid
    Shahidsales, Soodabeh
    Hasanzadeh, Malihe
    Jazayeri, Mir Hadi
    Hassanian, Seyed Mahdi
    Ferns, Gordon A.
    Saghafi, Nafiseh
    Avan, Amir
    JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (07) : 5170 - 5179
  • [8] Vitamin D as a Potential Therapeutic Target and Prognostic Marker for Colorectal Cancer
    Bintintan, Vasile V.
    EBIOMEDICINE, 2018, 31 : 11 - 12
  • [9] Identification of BIK as an unfavorable prognostic marker and novel therapeutic target in microsatellite stable colorectal cancer harboring KRAS mutations
    Liu, Peng
    Jiao, Feng
    Zhang, Zhenghua
    Zhao, Feilong
    Cai, Jinping
    Chen, Shiqing
    Fu, Tao
    Li, Min
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (11): : 5300 - +
  • [10] Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer
    Zhang, Hao
    Liang, Xi
    Duan, Chao
    Liu, Caigang
    Zhao, Zuowei
    PLOS ONE, 2014, 9 (09):